NCT04727112

Brief Summary

Asthma screening of 493 asthma patients

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
493

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2000

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2000

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2003

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2004

Completed
9.9 years until next milestone

First Submitted

Initial submission to the registry

November 5, 2013

Completed
7.2 years until next milestone

First Posted

Study publicly available on registry

January 27, 2021

Completed
Last Updated

January 27, 2021

Status Verified

January 1, 2021

Enrollment Period

3 years

First QC Date

November 5, 2013

Last Update Submit

January 26, 2021

Conditions

Asthma

Keywords

asthmaairway hyperresponsivenessasthma management

Outcome Measures

Primary Outcomes (2)

  • ACQ

    Questionnaire based

    2004

  • AQLQ

    Questionnaire based

    2004

Secondary Outcomes (1)

  • FEV1

    2004

Study Arms (2)

asthma and rhinitis

Screening of patients with upper and lower airway symptoms

Drug: Usual care versus primary care

asthma and rhintis follow-up

same Group as screened in 2000, was followed up three years later

Drug: Usual care versus primary care

Interventions

Usual care versus primary careDRUG

RCT study

Also known as: RCT study, usuar care in specialist setting (GINA and ARIA)
asthma and rhinitisasthma and rhintis follow-up

Eligibility Criteria

Age15 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Population based asthma study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

AsthmaRespiratory Hypersensitivity

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Vibeke Backer, MD

    Bispebjerg Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 5, 2013

First Posted

January 27, 2021

Study Start

January 1, 2000

Primary Completion

January 1, 2003

Study Completion

January 1, 2004

Last Updated

January 27, 2021

Record last verified: 2021-01